152 related articles for article (PubMed ID: 14972521)
1. Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation.
Portis T; Longnecker R
Virology; 2004 Jan; 318(2):524-33. PubMed ID: 14972521
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
Portis T; Longnecker R
Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
[TBL] [Abstract][Full Text] [Related]
3. Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction.
Swart R; Fruehling S; Longnecker R
Virology; 1999 Oct; 263(2):485-95. PubMed ID: 10544120
[TBL] [Abstract][Full Text] [Related]
4. Role of latent membrane protein 2 isoforms in Epstein-Barr virus latency.
Rechsteiner MP; Bernasconi M; Berger C; Nadal D
Trends Microbiol; 2008 Nov; 16(11):520-7. PubMed ID: 18835714
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.
Swanson-Mungerson MA; Caldwell RG; Bultema R; Longnecker R
J Virol; 2005 Jun; 79(12):7355-62. PubMed ID: 15919890
[TBL] [Abstract][Full Text] [Related]
6. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice.
Caldwell RG; Brown RC; Longnecker R
J Virol; 2000 Feb; 74(3):1101-13. PubMed ID: 10627520
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus: exploiting the immune system.
Thorley-Lawson DA
Nat Rev Immunol; 2001 Oct; 1(1):75-82. PubMed ID: 11905817
[TBL] [Abstract][Full Text] [Related]
9. K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.
Steinbrück L; Gustems M; Medele S; Schulz TF; Lutter D; Hammerschmidt W
J Virol; 2015 Jul; 89(14):7248-61. PubMed ID: 25948739
[TBL] [Abstract][Full Text] [Related]
10. B cell receptor signal strength determines B cell fate.
Casola S; Otipoby KL; Alimzhanov M; Humme S; Uyttersprot N; Kutok JL; Carroll MC; Rajewsky K
Nat Immunol; 2004 Mar; 5(3):317-27. PubMed ID: 14758357
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction.
Miller CL; Lee JH; Kieff E; Burkhardt AL; Bolen JB; Longnecker R
Infect Agents Dis; 1994; 3(2-3):128-36. PubMed ID: 7812651
[TBL] [Abstract][Full Text] [Related]
12. The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases.
Ikeda M; Ikeda A; Longan LC; Longnecker R
Virology; 2000 Mar; 268(1):178-91. PubMed ID: 10683340
[TBL] [Abstract][Full Text] [Related]
13. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
14. LMP2A survival and developmental signals are transmitted through Btk-dependent and Btk-independent pathways.
Merchant M; Longnecker R
Virology; 2001 Dec; 291(1):46-54. PubMed ID: 11878875
[TBL] [Abstract][Full Text] [Related]
15. Induction of T-cell immunity against Epstein-Barr virus-associated tumors by means of adenovirally transduced dendritic cells.
Sun H; Yao K; Chen Y; Zhou F
Chin Med J (Engl); 2004 Oct; 117(10):1558-63. PubMed ID: 15498383
[TBL] [Abstract][Full Text] [Related]
16. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
[TBL] [Abstract][Full Text] [Related]
17. Expression and characterization of N-terminal domain of Epstein-Barr virus latent membrane protein 2A in Escherichia coli.
Park SJ; Seo MD; Lee SK; Ikeda M; Longnecker R; Lee BJ
Protein Expr Purif; 2005 May; 41(1):9-17. PubMed ID: 15802216
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus LMP2A imposes sensitivity to apoptosis.
Swanson-Mungerson M; Bultema R; Longnecker R
J Gen Virol; 2010 Sep; 91(Pt 9):2197-202. PubMed ID: 20484564
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma.
Portis T; Dyck P; Longnecker R
Blood; 2003 Dec; 102(12):4166-78. PubMed ID: 12907455
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.
Caldwell RG; Wilson JB; Anderson SJ; Longnecker R
Immunity; 1998 Sep; 9(3):405-11. PubMed ID: 9768760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
